, and the 36-month beta value for FBIO is at 2.04. Analysts have varying views on the stock, with 6 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
The average price suggested by analysts for FBIO is $7.58, which is $7.91 above the current market price. The public float for FBIO is 75.73M, and currently, shorts hold a 0.93% of that float. The average trading volume for FBIO on May 26, 2023 was 694.19K shares.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
Sponsored
FBIO) stock’s latest price update
The stock of Fortress Biotech Inc. (NASDAQ: FBIO) has increased by 2.84 when compared to last closing price of 0.49.Despite this, the company has seen a loss of -1.97% in its stock price over the last five trading days.
FBIO’s Market Performance
FBIO’s stock has fallen by -1.97% in the past week, with a monthly drop of -31.80% and a quarterly drop of -32.69%. The volatility ratio for the week is 6.98% while the volatility levels for the last 30 days are 7.81% for Fortress Biotech Inc. The simple moving average for the last 20 days is -24.10% for FBIO’s stock, with a simple moving average of -37.31% for the last 200 days.
FBIO Trading at -29.52% from the 50-Day Moving Average
After a stumble in the market that brought FBIO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -61.90% of loss for the given period.
Volatility was left at 7.81%, however, over the last 30 days, the volatility rate increased by 6.98%, as shares sank -34.98% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -32.61% lower at present.
During the last 5 trading sessions, FBIO fell by -3.17%, which changed the moving average for the period of 200-days by -58.79% in comparison to the 20-day moving average, which settled at $0.6518. In addition, Fortress Biotech Inc. saw -22.92% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at FBIO starting from ROSENWALD LINDSAY A MD, who purchase 2,395,209 shares at the price of $0.83 back on Feb 10. After this action, ROSENWALD LINDSAY A MD now owns 15,349,091 shares of Fortress Biotech Inc., valued at $2,000,000 using the latest closing price.
WEISS MICHAEL S purchase 1,197,604 shares at $0.83 during a trade that took place back on Feb 10, which means that WEISS MICHAEL S is holding 14,752,034 shares at $999,999 based on the most recent closing price.
Stock Fundamentals for FBIO
Current profitability levels for the company are sitting at:
- -268.76 for the present operating margin
- +55.26 for the gross margin
The net margin for Fortress Biotech Inc. stands at -114.30. Equity return is now at value -169.10, with -29.70 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 1.80.
Conclusion
In conclusion, Fortress Biotech Inc. (FBIO) has had a bad performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
